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Abstract
Background: Morbidity estimates between different GP registration networks show large, unexplained variations.
This research explores the potential of modeling differences between networks in distinguishing new (incident)
cases from existing (prevalent) cases in obtaining more reliable estimates.
Methods: Data from five Dutch GP registration networks and data on four chronic diseases (chronic obstructive
pulmonary disease [COPD], diabetes, heart failure, and osteoarthritis of the knee) were used. A joint model (DisMod
model) was fitted using all information on morbidity (incidence and prevalence) and mortality in each network,
including a factor for misclassification of prevalent cases as incident cases.
Results: The observed estimates vary considerably between networks. Using disease modeling including a
misclassification term improved the consistency between prevalence and incidence rates, but did not systematically
decrease the variation between networks. Osteoarthritis of the knee showed large modeled misclassifications,
especially in episode of care-based registries.
Conclusion: Registries that code episodes of care rather than disease generally provide lower estimates of the
prevalence of chronic diseases requiring low levels of health care such as osteoarthritis. For other diseases,
modeling misclassification rates does not systematically decrease the variation between registration networks. Using
disease modeling provides insight in the reliability of estimates.
Keywords: Incidence-prevalence-mortality model, General practitioner, General practice registration, Morbidity,
Public health, Burden of disease
Background and goal
For health policy purposes, population health is moni-
tored on a regular basis. An important measure for
population health is the morbidity in the population:
what are the most important diseases and how are dis-
ease patterns changing over time? Registries in general
practice are key sources for morbidity estimates, espe-
cially if all people are registered in a general practice and
the general practitioner (GP) is the gatekeeper of health
care. In this case, the population registered in general
practices is representative of the whole population out-
side of long term health care facilities. Furthermore, if
the general practitioner acts as a gatekeeper of health
care, diagnoses from medical specialists and other health
care providers will also be known by the general practi-
tioner. In the Dutch system, both conditions are met.
Furthermore, the Netherlands has the fortunate position
of having many general practice registration networks.
These networks constitute of several general practices,
all collecting information on morbidity and health care
in a standardized manner [1].
Previous research has shown that morbidity estimates
between different general practice registration networks
vary considerably [2]. These differences could not be ex-
plained by differences in characteristics of the patient
population or in the characteristics of the general practice
[3, 4]. Most likely, differences in registration procedures
contribute to this variation. In particular, the method to
distinguish new cases (incidence) from existing cases
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(prevalence) is expected to have an effect on these esti-
mates. General practice registration networks can count
either “episodes of disease” or “episodes of care”. In “epi-
sode of care”-based registries, the GP indicates whether
the episode is an incident (new) or prevalent one, and for
chronic diseases that do not require continuous care, mul-
tiple care episodes can be present for the same episode of
disease. In “episode of disease”-based registries, only the
presence of a (new) disease is counted (Fig. 1). For public
health purposes, we want to summarize data from both
sources into one measure in order to use all available in-
formation. Therefore, we developed a method to enhance
the comparability of morbidity estimates from different
registries.
The primary aim of this study is to ascertain the
consistency of estimates of incidence and prevalence
rates of a number of chronic diseases important for pub-
lic health monitoring. Incidence, prevalence, and mortal-
ity are consistent if the prevalence is a credible function
of inflow (incidence) and outflow (institutionalization
and mortality), taking the possibility of time trends into
account. Consistent estimates are needed for chronic
disease modeling [5]. Furthermore, consistency improves
the reliability of the incidence and prevalence estimates.
The secondary aim of this research is to investigate to
what extent differences between the networks in the
method of distinguishing incident from prevalent cases
explain differences in morbidity outcomes between GP
registration networks.
Methods
Five general practice registration networks
We used data from 2010 from five Dutch general prac-
tice registration networks. Although more registration
networks exist in the Netherlands [1], these five have
been used for population health monitoring [6, 7].
Table 1 shows the full names, abbreviations, and some
characteristics of these five networks in 2010. One net-
work has a population representative for the Dutch
population. The other networks operate in specific geo-
graphical areas in the Netherlands. Networks differ in
size, ranging from 14,000 to 270,000 person years and
4–51 general practices.
An important difference between the networks is
whether “episodes of care” or “episodes of disease” are
used as the source of morbidity estimates. An “episode
of disease” refers to the presence of a disease, while an
“episode of care” refers to the treatment of a disease [8].
In this latter type of registries, only those diseases are
counted for which care was provided. Information on
contacts (consultations, visits, phone calls, prescriptions)
form the basis for the construction of “care episodes”
and with that for the estimates of morbidity rates
[9–12]. For example, a patient with known hearing loss
who did not contact the GP for this problem in a cer-
tain time frame, counts as a prevalent case in “episode
of disease”-based registries, but does not count as a
prevalent case in “episode of care”-based registries
during that time frame.
The networks all use data that are extracted from rou-
tine health care systems, filled on a daily basis by the
health care providers in general practice. These systems all
have roughly similar data-tables, defined in the HIS-
reference model (https://www.nhg.org/themas/publicaties/
his-referentiemodel). GP practices open a record for each
contact with a patient and for each contact with a GP an
ICPC code is assigned. That could be a new code, but the
contact can also be made part of an existing open episode
of disease or care. For chronic diseases, such episodes stay
open indefinitely in disease-based networks. For diseases
requiring continuous care, the episodes stay open in all
networks. New contacts can be assigned to an existing
open episode. When the contact refers to multiple health
problems, multiple ICPC codes can be entered.
Fig. 1 The difference between networks based on episodes of care and episodes of disease
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The records from the routine health care systems
are transferred to the network coordinating group at
fixed times (varying between the networks, but at
least once a year). The data transferred also include
the number of patients registered with the GP prac-
tice, including those that did not contact the GP
practice in the period of data capture. Data from dif-
ferent transfer moments can be linked using unique
patient numbers, and thus patients can be followed
over time. Dates of leaving the practise are not always
registered. If a patient is registered at one data trans-
fer date, but not at the next, the patient is assumed
to contribute halve the period to the person years in
observation.
Changes in the data can be made in the process of
routine health care, where GPs remove errors when
detected. Data are fixed, however, at the moment of
transfer to the network coordinating center. The co-
ordinating centers apply data cleaning, which can in-
clude procedures that further link contacts together
into episodes.
In an earlier publication, we described these five
networks in more detail [1]. Apart from incidence
and prevalence rates, the networks also provided data
on the number of patients that died. Three of the five
networks had information on the number of patients
that left the practice because they moved to a nursing
home. This information is important, because these
patients no longer receive general practice care from
their general practitioner and have a larger odds of
dying in the next year.
Incidence and prevalence of four chronic diseases
Four chronic diseases were selected: chronic obstructive
pulmonary disease (COPD) (International Classification
for Primary Care [ICPC] codes R91 and R95), diabetes
(ICPC code T90), heart failure (ICPC code K77), and
osteoarthritis of the knee (ICPC code L90). For these
diseases, general practice registration networks are the
main data source, and these represent a broad spectrum
of chronic diseases. Furthermore, these diseases differ in
the expected frequencies of visits to the GP. For
diabetes, guidelines require general practitioners to see
their patients several times each year. On the other ex-
treme, patients once diagnosed with osteoarthritis of the
knee do not need to contact their general practitioner
very often for this condition.
In this study, estimates of incidence and prevalence
rates from networks that use “episodes of care”-based
registration methods are obtained by using the infor-
mation of three calendar years in the registration.
Only patients who were registered in GP practice on
the first of January 2008 were included in this ana-
lysis. To estimate the incidence and prevalence in
2010, we included diagnoses of the specific disease in
these patients in the 2 years prior to 2010, and only
count a case as an incident case when no episode of
care starting before 2010 was observed. Three years
were taken as earlier work showed that this is long
enough for diseases requiring continuous GP care,
while a longer period would imply excluding more
patients (those not registered with the GP for that
longer period).
For disease modeling, transition rates from healthy to
the “with disease” state are needed.
These incidence (density) rates were calculated as
the ratio of the number of new cases registered di-
vided by the number of person years free of disease.
The latter was estimated from the total number of
person years, the number of existing cases of the dis-
ease (point prevalence), the number of new cases of
the disease (incidence), and the number of persons
with the disease that left the general practice due to
death or institutionalization. In “episode of disease”-
based registries, the point prevalence was calculated
as the number of known patients with disease on the
first of January divided by the total number of
patients in the registration at that moment. For
Table 1 General characteristics of five Dutch general practice registration networks in 2010
LINH CMR-N RNUH-LEO Transition RNH
Full name Netherlands Information
Network of General Practice
Continuous Morbidity
Registration Nijmegen







Localization National Nijmegen and
surrounding area





270,000 14,000 44,000 14,000 88,000
Number of GPs/
practices
85a/51 11/4 20/4 8/5 65/22
Source of data Episode of care Episode of disease Episode of disease Episode of care Episode of disease
aFull time equivalent of GP’s working in the LINH practices
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networks based on “episodes of care,” it was calcu-
lated as the number of patients seen for the disease
in the period of 2008–2010 minus the new, incident
patients seen only in 2010, divided by the number of
total number of patients registered on the first of
January of 2010. The number of patients on the first
of January was not provided by all registries, and was
therefore estimated as being equal to the number of
person years in 2010, implicitly assuming a stable
population.
Subsequently, we estimated the incidence and preva-
lence rates for the whole Dutch population based on the
information in all five networks in two different ways.
First, the simple mean over the five registries of the age-
and sex-standardized prevalence and incidence is calcu-
lated. Second, a multi-level model is fitted to the data
(with registration network as level, that is, as random
intercept), and the age-standardized predicted value
from this model is used as estimate. For incidence, a
random intercept Poisson model was fitted, and for
prevalence a random intercept logistic model was fitted.
Third degree polynomials were considered for age and
for the interaction of age with sex. We selected the sim-
plest model that fitted the data statistically significantly
better than all other models (for more detail on this
method see [5]).
Disease modeling
We used disease modeling to check the consistency
of the prevalence and incidence figures in each of the
networks. For chronic diseases, disease modeling only
involves incidence, prevalence, and mortality. By def-
inition, no data on recovery of disease is needed. In
the first step of disease modeling, we projected the
number of prevalent cases in the network in a hypo-
thetical cohort of newborns, by applying the disease
inflow (incidence) and disease outflow (mortality and
institutionalization of those with the disease) data of
the network to that cohort. This implicitly assumes
no important time-trends in incidence and excess
mortality (within the period in which the current
prevalent cases arose). Also, it assumes that those en-
tering the GP population, and those leaving it for
other reasons than death or institutionalization, are
similar to those of similar age and sex who stay in
the population. We then compared this projected
prevalence to the observed prevalence in all age and
gender groups.
Second, we fitted a joint model (the DisMod model)
using all information on morbidity and mortality in
each network to construct the most reliable estima-
tions of prevalence and incidence rates of these four
diseases for each network under the assumption of
stable incidence and survival probabilities over time.
See appendix A for the equations and assumptions of
the DisMod model. The model included a misclassifi-
cation factor that allows for misclassification of a per-
centage of prevalent cases as incident cases, in order
to see whether this might explain the observed lack
of prevalent cases compared to incident cases in some
situations. We thus assumed that misclassification of
incident cases as prevalent cases would be relative
rare, and thus can be ignored. We fitted this model
by maximum likelihood, separately for each registra-
tion. From the fitted model, we calculated the stan-
dardized incidence and prevalence rates. For each
registration, we generated 1,000 model parameter
values from the estimated model parameter vector
and its covariance matrix in order to generate the
confidence interval. As the numbers of deaths were
low in the smaller registrations, institutionalization
data were not available in two registrations and more-
over, there were clear indications of under registration
of deaths in most registrations, the model did not
converge reliably for all registrations (see appendix B
for the life expectancies as calculated from the mor-
tality data in each registration). Therefore, we decided
to use the mortality and institutionalization data from
the largest registration (LINH) for all registrations. As
can be seen in appendix B, the mortality data from
this network where the best calibrated rates in terms
of magnitude. The registration-specific standardized
incidence and prevalence rates were then combined
into an overall standardized incidence or prevalence,
using a random-effect meta-analytic model (R package
meta, function metagen) on the logarithm of the stan-
dardized incidence or prevalence and its standard
error.
Results
The mean incidence of diabetes is 4.6 per 1,000
(simple mean), and this figure varies from 3.7 in the
CMR-N registration to 5.4 in the Transition registra-
tion. Table 2 shows the incidence rates in all registra-
tion networks, for all of the four diseases, as well as
the two different estimates of the mean morbidity.
The highest estimate of incidence is 1.5 (diabetes) to
2.7 (heart failure) times higher than the lowest esti-
mate. The fitted means are generally a little lower
than the simple means. The most important reason is
that LINH has lower estimates of incidence while the
data from this network determine a larger proportion
in the calculation of the mean, because this network
includes much more patients compared to the other
networks. For prevalence rates, the differences be-
tween simple and fitted mean are in the same order
of magnitude (see Table 3). Only differences in the
prevalence of osteoarthritis of the knee are larger.
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These vary between 1.0% in the RNUH-LEO network
to 3.9% in the CMR-N network. These differences are
reflected in the width of the confidence intervals of
the fitted means.
Disease modeling: examine consistency of incidence,
prevalence, and mortality rates
Figure 2 shows the observed and projected prevalence
rates of diabetes in women in the different general
practice registration networks by age. In all networks,
the projected prevalence rates resembled the observed
rate relatively well, meaning that incidence, prevalence
and mortality rates were consistent. Only at older
ages, the observed prevalence was (a little) lower than
expected. This means that the prevalence was ex-
pected to be higher, based on the current incidence
and mortality rates. For men, the gap between ob-
served and projected prevalence rates was larger than
for women (results not shown).
The results for heart failure also show incidence,
prevalence, and mortality to be rather consistent (see
appendix B). For the other two diseases we studied, the
consistency was lower. The prevalence rates of COPD
as registered by the networks were lower than the
projected prevalence rates based on the currently ob-
served incidence and mortality rates. Only in the LINH
network were incidence, prevalence, and mortality rates
consistent. Figure 3 shows these results for women, but
results for men are similar. Results for osteoarthritis
show that prevalence rates were rather consistent with
incidence rates and mortality for two networks (RNH
and CMR-N). The other three networks (Transition,
LINH, RNUH-LEO) had observed prevalence rates that
were much lower than projected rates (see appendix B).
An important reason for the result that a lower than
projected prevalence rate was observed for older ages is
that all registration networks underestimate mortality.
Appendix C shows that the age-specific life expectan-
cies calculated from the mortality figures as registered
by the different networks are much higher than mortal-
ity data from Statistics Netherlands. Due to this under-
estimation of mortality in the networks, the projected
prevalence is too high. The reason is that this preva-
lence is based on incidence (inflow) and mortality and
institutionalization (outflow). If mortality is actually
higher than registered, the outflow with which we do
the calculations is too low, and the subsequent
projected prevalence is too high.
Table 2 Incidence (per 1,000) of four diseases for each network, standardized for age and gender in 2010
Diabetes COPD Heart failure Osteoarthritis of the knee
Observed estimates
LINH 4.1 2.2 1.8 2.4
CMR-N 3.7 2.6 2.4 3.4
RNUH-LEO 4.7 3.0 2.6 3.5
Transition 5.4 3.9 4.8 4.5
RNH 4.8 4.4 2.2 3.2
Summary estimates
Simple mean 4.6 3.2 2.8 3.4
Fitted mean (95% CI) 4.5 (4.1 – 4.9) 3.0 (2.3 – 3.8) 2.5 (1.8 – 3.2) 3.2 (2.6 – 3.7)
Table 3 Prevalence (per 1,000) of four diseases for each network, standardized for age and gender in 2010
Diabetes COPD Heart failure Osteoarthritis of the knee
Observed estimates
LINH 54 26 11 12
CMR-N 48 22 13 39
RNUH-LEO 50 25 11 10
Transition 61 22 18 20
RNH 57 33 8 28
Summary estimates
Simple mean 54 25 12 22
Fitted mean (95% CI) 54 (50 – 58) 26 (22 – 29) 12 (9 – 15) 19 (11 – 28)
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Disease modeling: reliable and consistent estimates of
prevalence and incidence
Table 4 shows the fractions of prevalent cases esti-
mated to be misclassified as incident cases according
to our model. High misclassification rates were found
for osteoarthritis of the knee (with the exception of
the CMR-N, a registration that has been in place
since 1971, where the misclassification was not statis-
tically significant), while no statistically significant
misclassification was present for heart failure. Note
that the model assumes that no patients with the dis-
ease are missed in the registration. When prevalent
cases are missed, this will also result in a higher esti-
mate for the number of misclassified cases, so a high
misclassification rate could also indicate that some
patients are missed by the registration. When disease
modeling takes this misclassification into account,
modeled incidence rates are expected to be lower
than observed incidence rates. Vice versa, modeled
prevalence rates are expected to be higher than
observed rates. This effect is expected to be largest
for osteoarthritis of the knee, followed by COPD and
diabetes, and absent for heart failure.
Table 5 shows the incidence rates from the joint
model. In a few cases, the confidence intervals around
the estimates for individual registrations are wide, in-
dicating that the model does not fit these observed
data well. This is an important sign that the incidence
and prevalence as registered are not consistent with
those expected in a relatively stable population. As
Fig. 2 Observed and projected prevalence of diabetes mellitus in women in 2010 by GP network
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Fig. 3 Observed and projected prevalence of COPD in women in 2010 by GP network
Table 4 Estimated misclassification fraction: percentage of prevalent case that is misclassified as an incident case as estimated by
the DISMOD model
Diabetes COPD Heart failure Osteoarthritis of the knee
LINH males 0a 0a 0a 14.1 (11.3-16.9)
LINH females 0a 1.1 (0-2.5) 0a 12.4 (10.4-14.2)
CMR_N males 1.5 (0-4.2) 1.4 (0-6.7) 0a 4.0 (0-9.0)
CMR_N females 2.8 (0-5.7) 4.7 (0-10.7) 0a 0a
RNUH-LEO males 3.8 (1.9-5.8) 3.6 (0.1-7.0) 7.2 (0-17.0) 26.4 (17.8-35.0)
RNUH-LEO females 2.7 (0.7-4.6) 4.7 (1.7-7.7) 0a 21.6 (15.7-27.6)
Transition males 2.3 (0.7-4.6) 4.4 (0-10.7) 0a 17.3 (6.3-28.3)
Transition females 0a 9.0 (2.4-15.6) 0a 9.1 (3.7-14.4)
RNH males 1.6 (0.5-2.8) 4.8 (2.9-6.7) 3.1 (0-9.1) 6.1 (4.1-8.2)
RNH females 1.4 (0.4-2.5) 6.4(4.7-8.2) 5.0 (0-11.5) 3.4 (2.0-4.9)
aNo confidence interval calculated because the point estimate is on the boundary of the parameter space
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expected, incidence was lower in these models as
compared to the observed rates, as copied from
Table 2. For the diseases with low misclassification
rates (diabetes and heart failure), this difference was
only moderate. The difference was considerable for
osteoarthritis of the knee. In these cases, the
estimated overall incidence was less than half of the
registered incidence. After applying the DisMod
model, the ranking of network incidence rates for
osteoarthritis of the knee resembled the ranking of
the observed prevalence rates, rather than that of the
observed incidence rates. Another effect of the joint
modeling is that incidence rates are also based on the
observed prevalence rates, which are based on larger
numbers than observed incidences rates. Therefore,
the confidence intervals around the incidence rates
from the joint model are narrower than those from
the model on incidence data alone.
Table 6 shows the prevalence rates from the joint
model. The estimated prevalence from the DisMod-
model was for COPD and osteoarthritis of the knee
slightly higher than the observed prevalence, as was
expected. The difference, however, was rather small
compared to the confidence intervals. For heart
failure, where misclassification was estimated to be
zero in most cases, the estimated prevalence from the
DisMod model was slightly lower than the observed
prevalence, but again the difference was small com-
pared to the confidence interval. The prevalence of
diabetes was similar for both methods.
Discussion
Prevalence and incidence data from “episode of care”
registries based on data that include GP visits from 2 year
before baseline yield consistent estimates for diabetes,
COPD, and heart failure. Osteoarthritis of the knee, how-
ever, could only be consistently estimated from data of a
long-running “episode of disease” registration that also
registers prevalent diseases of new patients. Using disease
modeling including a misclassification term did improve
the consistency between prevalence and incidence rates,
but did not systematically decrease the variation between
networks. This DisMod modeling mostly affected the
incidence rates, while prevalence rates did not change im-
portantly. Osteoarthritis of the knee showed a different
pattern, as inconsistency between prevalence and inci-
dence rates were large, and are probably not only due to
misclassification of incidence as prevalence, but also to
missing cases altogether, because prevalent patients with
osteoarthritis might not have visited the GP for this dis-
ease in a 3 year period. Including misclassification in the
disease modeling cannot account for this. Missing cases is
Table 5 Incidence (per 1,000) as estimated with the DisMod model of four diseases for each network, standardized for age and
gender
Diabetes COPD Heart failure Osteoarthritis of the knee
LINH 4.0 (3.8 – 4.2) 2.1 (1.9 – 2.2) 2.0 (1.9 – 2.2) 0.8 (0.8 – 0.9)
CMR_N 3.3 (3.0 – 3.8) 1.9 (1.7 – 2.4) 2.9 (2.4 – 3.9) 3.0 (2.7 – 3.6)
RNUH-LEO 3.2 (3.0 – 3.6) 2.1 (1.9 – 2.4) 2.5 (2.2 – 2.9) 0.9 (0.8 – 1.2)
Transition 4.8 (4.4 – 5.5) 2.2 (2.0 – 3.2) 6.3 (5.3 – 8.1) 1.5 (1.4 –1640)
RNH 3.9 (3.7 – 4.1) 2.5 (2.3 – 2.7) 2.0 a 1.9 (1.8 – 2.0)
Simple mean over networks 3.8 (3.4 – 4.2) 2.2 (1.9 – 2.4) 2.3 (2.1 – 2.5) 1.3 (0.8 – 2.3)
Fitted mean (table 2) 4.5 (4.1 – 4.9) 3.0 (2.3 – 3.8) 2.5 (1.8 – 3.2) 3.2 (2.6 – 3.7)
aConvergence not reliable: no calculation of confidence intervals
Table 6 Prevalence (per 1.000) as estimated with the DisMod model, for four diseases for each network, standardized for age and
gender
Diabetes COPD Heart failure Osteoarthritis of the knee
LINH 54 (52 – 55) 26 (25 – 27) 10 (10 – 11) 14 (10 – 14)
CMR-N 48 (45 – 52) 22 (21 – 27) 12 (10 – 15) 39 (31 – 44)
RNUH-LEO 51 (48 – 53) 26 (23 – 27) 11 (10 – 12) 13 (10 – 22)
Transition 61 (57 – 65) 23 (21 – 32) 18 (16 – 21) 22 (18 – 494)
RNH 58 (55 – 59) 34 (32 – 35) 9 a 29 (20 – 30)
Simple mean over networks 54 (51 – 58) 27 (23 – 32) 10 (08 – 12) 22 (13 – 34)
Fitted mean (table 2) 54 (50 – 58) 26 (22 – 29) 12 (09 – 15) 19 (11 – 28)
aConvergence not reliable: no calculation of confidence intervals
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to be expected in registries where morbidity is based on
“episodes of care,” but also one of the “episodes of
disease”-based registrations (RNUH-LEO) yielded large
discrepancies between incidence and prevalence. For the
other two networks where morbidity is based on “episodes
of disease” the consistency was better; that is, observed
and projected prevalence matched considerably better.
This was especially the case in CRM-N, a very long-
running disease episode-based registry.
These results are not unexpected, because osteoarth-
ritis of the knee is a protracted disease, where patients
pay fewer visits to their GP (for this specific disease)
compared to patients with the other diseases, and visits
might be many years apart. The reason is not only that
no regular checkups are needed, but also because pa-
tients can visit a physical therapist without referral from
their general practitioner. Especially if the morbidity
registration is based on “episodes of care,” this leads to
underestimation of prevalence of disease as well as to
misclassifications between incidence and prevalence
rates. For instance, in these registrations, osteoarthritis
patients, who visit the GP in the year of registration, but
did not visit their physician in the 2 years before base-
line, will be missed as prevalent cases. These will be
counted as incident cases instead, while those not visit-
ing the GP in all 3 years will not be counted at all. For
such diseases, a longer period will be needed to obtain
reliable estimates of incidence and prevalence.
Differences between the networks are adjusted for age
and gender differences of the enlisted population. We did
not adjust for other characteristics of the populations,
such as socioeconomic status, ethnicity, and degree of
urbanization. In an earlier study, we already showed that
these characteristics did not explain any of the variance
between networks [3]. The same was found for differences
between GPs and general practices. Differences in type of
practice (solo, duo, or group), mean years of medical ex-
perience, and distance to nearest hospital did not explain
the variance between the networks [4].
There are further factors in procedures per registration
that could influence the incidence and prevalence from
GP registrations that we could not study here. For
instance, if registrations differ in the way they enter pa-
tients that purely received secondary care, making differ-
ent choice in assigning ICPC codes (due to differences
in the clinical definition of the disease or errors in diag-
nosis) or the frequency in updating earlier diagnoses.
Such factors can only be ruled out when strict clinical
definitions are applied.
In this study, estimates of incidence and prevalence
rates from networks that use “episodes of care”-based
registration methods are obtained by using the informa-
tion of three calendar years in the registration. To esti-
mate the incidence and prevalence of 2010, we included
diagnoses of the specific disease in these patients in the
2 years prior to 2010. Until now, only 1 year estimates
were used to estimate morbidity in the Netherlands. In
this study, we analyzed the misclassifications, and ob-
served that registered incident cases in 2010 regularly
had already had episodes in 2008 and 2009 (data not
shown). Using data from 2010 only led to predicted
prevalence rates that were clearly inconsistent with the
observed ones. We concluded therefore that using 1 year
data leads to important misclassification in “episode of
care”-based registries. Therefore, we used the 3 year data
and we also recommend that this is done in future
research.
We and others [3, 4] looked at differences between
registration network within the same country and found
large differences that could not be fully explained. When
comparing registration-based data between countries, we
expected similar differences in the organization of data col-
lection as between networks in the Netherlands. Moreover,
while registration networks in the Netherlands share a
health care system and GPs that are trained by and large by
the same medical schools, this will not be the case for net-
works based in different countries. So in the international
context confronting prevalence and incidence, data is there-
fore even more important.
Mortality in general practice was generally underesti-
mated. We did expected mortality to be slightly lower
than official statistics, because those with highest mortality
rates move to a nursing home. These homes supply med-
ical care for their patients, and so these patients leave the
general practitioner and the general practice registration.
However, this effect should be similar for all registrations,
while we observed clear differences between registrations
with regards to the amount of underestimation. However,
in case of the LINH the higher mortality compared to
other registries might well be an artifact. In this registry,
GPs report every three months whether patients are still
present, and time of death in those who died was mostly
not available. Because of this, the registered cases of death
were from a period with unknown length that we assumed
to be 1 year, but was on average probably longer. In our
models, we also included the patients who moved to an
institution. In subsequent research, we advise to use link-
age to national mortality data when possible, accounting
for privacy legislation.
In order to derive consistent estimates of prevalence,
incidence and excess mortality we fitted a joint model to
all data. A crucial assumption in this model is that the
disease process is stable over time. That is, that inci-
dence and mortality have not changed importantly in
recent years (within the duration of the disease). For dia-
betes in women, this might not be realistic, as the inci-
dence has increased in recent years. Data from the RNH
show that the incidence of diabetes doubled in women
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and tripled in men in the period 1990–2007. Data from
CMR-N, showed an increase of 40% and 70% respect-
ively. This implies that past incidence rates were lower
than those expected under our model. This might gener-
ate a spuriously high misclassification rate. In situations
where the disease-related mortality or the incidence has
decreased in recent years, the observed prevalence is
lower than expected under our model, causing the mis-
classification rate to be spuriously low. Therefore, the
misclassification rates in Table 4 should be interpreted
with caution. However, time trends in incidence and
mortality can be assumed to be general trends in the
Dutch population, and should be the same for all reg-
istrations. The clear differences between registrations
in the degree in which observed and projected preva-
lence rates match, indicates that a large part of these
differences is due to registration-related misclassifica-
tion rather than to time trends.
Conclusion and recommendations
Using disease modeling to compare prevalence with inci-
dence rates is useful for detecting inconsistencies in the
data. Comparing observed and modeled data provides
insight into the reliability of the data. We applied this
for the Netherlands, but this will be useful too if data
are compared between registries from different coun-
tries. Data from 1-year “episode of care”-based data
turned out to be unreliable, while those based on a 3 year
period are sustainable. For osteoarthritis, this was only
the case for data based on a long-running “episodes of
disease” registration. For such chronic diseases for which
there is no regular contact with a physician, an “episodes
of disease” registry is essential; otherwise, too many
prevalent cases are missed to build a reliable morbidity
register. Disease modeling can be improved further by
using more reliable mortality data.
Appendix A
DisMod model
The DisMod model comprised of the following system
of equations:
i að Þ ¼ αi þ β1aþ β2a2 þ β3a3
m að Þ ¼ αm þ γ1aþ γ2a2 þ γ3a3
log RR að Þð Þ ¼ αRR þ δ1aþ δ2a2 þ δ3a3
em að Þ ¼ m að Þ RR að Þ−1ð Þ
p að Þ ¼ 1−p a−1ð Þð Þ  tr að Þ þ p a−1ð Þ  expð−em að ÞÞ1−p a−1ð Þð Þ tr að Þþ exp −i að Þð Þþp a−1ð Þ exp −em að ÞÞðð
tr að Þ¼
exp −em að Þð Þ− exp −i að Þð Þ
i að Þ−em að Þ
where
i(a): the incidence in the age interval [a,a + 1)
RR(a): the relative risk on mortality and outflow to in-
stitutions in those with the disease in the age interval
[a,a + 1) compared to those of similar age without the
disease
m(a): the mortality and outflow to institutions in those
without the disease in the age interval [a,a + 1)
em(a): the excess mortality (including outflow to insti-
tutions) in the age interval [a,a + 1). Excess mortality is
defined as the mortality rate in those with the disease
minus the mortality rate in those without the disease
p(a): the prevalence at the ath birthday
tr(a): the 1-year transition probability from the state
“without the disease” to the state “with disease”
In a second model, we further assumed that a fraction
ε of the prevalent cases at the start of each year is mis-
classified as an incident case in that year. We assume
that this fraction ε is the same for all ages. We estimated
ε by fitting this model to all data; that is, incidence,
prevalence and mortality, using maximum likelihood. In-
tuitively this implies that when the prevalence as calcu-
lated from the incidence and mortality, deviates from
the observed prevalence, a fraction ε is sought that
makes the deviation as minimal as possible.
In order to use maximum likelihood, we derived the
following expected values from this model for the ob-
served entities:
Expected incident cases:




p að Þ  N að Þ−ε  p að Þ  N að Þð Þ
þ 1
2
p aþ 1ð Þ  N aþ 1ð Þ−ε  p aþ 1ð Þ  N aþ 1ð Þð Þ
Expected number of deaths and institutionalizations in
those with the disease
RR að Þ m að Þ  pywith disease að Þ
Expected number of deaths and institutionalizations in
those without the disease
m að Þ  pywithout disease að Þ
where ε is the percentage of prevalent cases that is
misclassified as incidence cases by the physician, N(a) is
the number in the population at age a and py(a) the
number of person years with age a.
With these expected values we can write down the
likelihood of the model, assuming a Poisson probability
distribution for the number of incident cases and
deaths, and a binomial probability distribution for
prevalent cases.
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Appendix B
Figures for heart failure (men) and osteoarthritis of the
knee (women)
Fig. 4 Observed versus projected prevalence of heart failure in men in 2010 by GP network
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Fig. 5 Observed versus projected prevalence of osteoarthritis of the knee in women in 2010 by GP network
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Appendix C
Life expectancy calculated from mortality data from the
General Practice Registration Networks
The figure in this appendix shows the life expectancy for
each age group calculated on mortality as registered in
the different networks and on mortality data from Statis-
tics Netherlands (Statline). Calculations on mortality
data from the RNUH-LEO network, for example, show a
life expectancy of 60–65 year old men of almost 30 years,
whereas Statistics Netherlands calculates this at about
20 years. For all registration networks life expectancy es-
timates are too high. The LINH registration performed
best, but this might be an artifact, as mortality is LINH
is partly derived from periodical checks on whether a
patient was still registered, and the average period be-
tween check dates used comprise a period that was lar-
ger than 1 year, inflating the mortality rates.
Acknowledgments
The authors are indebted to C van den Dungen and Ronald Gijsen for their
help with interpreting the findings and suggestions on the work.
Funding
This research did not receive any specific grant from funding agencies in the
public, commercial, or not-for-profit sectors. The work was funded by the
Dutch Ministry of Health, Welfare and Sports.
Availability of data and materials
The aggregation level of the data brings a small disclosure risk for some
smaller subgroups. This small risk is compatible with use by researchers
bounded to non-disclosure but not with public sharing of the data.
Therefore data are not freely available.
Authors’ contributions
HB carried out the data analysis, constructed the statistical model and together
with NH, drafted the manuscript. MP cleaned and checked the data. MA, KB, JK,
MW, and MB were responsible for the delivery and elucidation of the data from
the RNH, CMR-N, LINH, RNUH-LEO, and CMR-N, respectively. All authors critically
reviewed draft manuscripts and suggested improvements. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Consent of individual persons for publication is not applicable.
Ethics approval and consent to participate
All practices gave permission to extract data from the electronic medical
records for research purposes and informed their patients who could object to
the use of their data. Extraction from the medical records occurred and the
data were de-identified. All registries comply with the Code of Conduct for
Health Research, which has been approved by the Dutch Data Protection
Authority (Autoriteit Persoonsgegevens, AP) for conformity with the applicable
Dutch privacy legislation. For this study, the registries supplied only aggregated
data and therefore additional approval of an external ethics committee was not
required.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1PO box 1 3720 BA, Bilthoven, The Netherlands. 2Biometrics, Wageningen
University, PO Box 16 6700AA, Wageningen, The Netherlands. 3Department
of Family Medicine, Maastricht University, P.O. Box 6166200, MD, Maastricht,
The Netherlands. 4Department of Public Health and Primary Care, Academic
Center for General Practice, Kapucijnenvoer 33, blok J, PB 70013000 Leuven,
KU, Belgium. 5Department of Primary and Community Care, Radboud
university medical center, Internal post ELG 117, P.O. Box 91016500 HB
Nijmegen, The Netherlands. 6Netherlands Institute for Health Services
Research (NIVEL), Otterstraat 118-124, P.O. Box 15683500 BN Utrecht, The
Netherlands. 7Department of Public Health and Primary Care, Leiden
University Medical Center, Postal zone V-0-P, PO-box 96002300 RC Leiden,
The Netherlands.
Received: 5 August 2016 Accepted: 23 March 2017
References
1. van den Dungen C, Hoeymans N, Gijsen R, van den Akker M, Boesten J,
Brouwer H, Smeets H, van der Veen WJ, Verheij R, de Waal M, Schellevis F,
Westert G. What factors explain the differences in morbidity estimations
among general practice registrations networks in the Netherlands? a first
analysis. Eur J Gen Pract. 2008;14 Suppl 1:53–62.
2. Gijsen R, Poos R. Using registries in general practice to estimate
countrywide morbidity in The Netherlands. Public Health. 2006;120:923–36.
3. van den Dungen C, Hoeymans N, Boshuizen HC, van den Akker M,
Biermans MCJ, van Boven K, Brouwer HJ, Verheij RA, de Waal MWM,
Schellevis FG, Westert GP. The influence of population characteristics on
variation in general practice based morbidity estimations. BMC Public
Health. 2011;11:887. doi:10.1186/1471-2458-11-887.
4. van den Dungen C, Hoeymans N, van den Akker M, Biermans MC, van
Boven K, Joosten JH, Verheij RA, de Waal MW, Schellevis FG, van Oers JA.
Do practice characteristics explain differences in morbidity estimates
between electronic health record based general practice registration
networks? BMC Fam Pract. 2014;15:176. doi:10.1186/s12875-014-0176-7.
Fig. 6 Life expectancy in men (top) and women (bottom), as
calculated on mortality data from the general practice registration
networks and from Statistics Netherlands
Boshuizen et al. Population Health Metrics  (2017) 15:13 Page 13 of 14
5. van Baal PH, Engelfriet PM, Hoogenveen RT, Poos MJ, van den Dungen C,
Boshuizen HC. Estimating and comparing incidence and prevalence of
chronic diseases by combining GP registry data: the role of uncertainty.
BMC Public Health. 2011;11:163. doi:10.1186/1471-2458-11-163. Published
online 2011 March 15.
6. A.E.M. de Hollander, N. Hoeymans, J.M. Melse, J.A.M. van Oers, J.J. Polder
(eds.). Zorg voor gezondheid. Volksgezondheid Toekomst Verkenning 2006
[Care for health. Public Health Status and Forecast Document 2006]. 2006;
Houten, Bohn, Stafleu en Van Lochem.
7. van der Lucht F, Polder JJ. Van gezond naar beter. Volksgezondheid Toekomst
Verkenning 2010. [From healthy to better. Public Health Status and Forecast
Document 2010]. 2010;RIVM report 270061005. Bilthoven, RIVM.
8. Hornbrook MC, Hurtado AV, Johnson RE. Health care episodes: definition,
measurement and use. Med Care Rev. 1985;42:2.
9. Biermans MC, Elbers GH, Verheij RA, Jan van der Veen W, Zielhuis GA,
Robbé PF. External validation of EPICON: a grouping system for estimating
morbidity rates using electronic medical records. J Am Med Inform Assoc.
2008a;15:770-5.
10. Biermans MC, Verheij RA, de Bakker DH, Zielhuis GA, de Vries Robbé PF.
Estimating morbidity rates from electronic medical records in general practice.
Evaluation of a grouping system. Methods Inf Med. 2008b;47:98-106.
11. Biermans MC, de Bakker DH, Verheij RA, Gravestein JV, van der Linden MW,
Robbé PF. Development of a case-based system for grouping diagnoses in
general practice. Int J Med Inform. 2008c;77:431-9.
12. Biermans MC, Spreeuwenberg P, Verheij RA, de Bakker DH, de Vries Robbé
PF, Zielhuis GA. Striking trends in the incidence of health problems in The
Netherlands (2002-05). Findings from a new strategy for surveillance in
general practice. Eur J Public Health. 2009;19:290–6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Boshuizen et al. Population Health Metrics  (2017) 15:13 Page 14 of 14
